BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12947323)

  • 1. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer.
    Kebebew E; Treseler PA; Duh QY; Clark OH
    Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer.
    Kebebew E; Treseler PA; Duh QY; Clark OH
    Surgery; 2000 Dec; 128(6):952-7. PubMed ID: 11114629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
    Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
    Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
    Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth.
    Ling MT; Wang X; Ouyang XS; Lee TK; Fan TY; Xu K; Tsao SW; Wong YC
    Oncogene; 2002 Dec; 21(55):8498-505. PubMed ID: 12466969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over expression of ID-1 in prostate cancer.
    Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
    J Urol; 2002 Jun; 167(6):2598-602. PubMed ID: 11992094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin: a differentiation marker in thyroid malignancies.
    Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
    Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the helix-loop-helix protein inhibitor of DNA binding-1 (ID-1) is activated by all-trans retinoic acid in normal human keratinocytes.
    Villano CM; White LA
    Toxicol Appl Pharmacol; 2006 Aug; 214(3):219-29. PubMed ID: 16494909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
    Visone R; Russo L; Pallante P; De Martino I; Ferraro A; Leone V; Borbone E; Petrocca F; Alder H; Croce CM; Fusco A
    Endocr Relat Cancer; 2007 Sep; 14(3):791-8. PubMed ID: 17914108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
    Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
    J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas.
    de Nigris F; Visconti R; Cerutti J; Califano D; Mineo A; Santoro M; Santelli G; Fusco A
    Cancer Res; 1998 Oct; 58(20):4745-51. PubMed ID: 9788632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of wild-type THRbeta1 suppresses the growth and invasiveness of human papillary thyroid cancer cells.
    Sedliarou I; Matsuse M; Saenko V; Rogounovitch T; Nakazawa Y; Mitsutake N; Namba H; Nagayama Y; Yamashita S
    Anticancer Res; 2007; 27(6B):3999-4009. PubMed ID: 18225562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.